COMPASS THERAPEUTICS, INC. (CMPX) Debt Components
- 2021-12-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term Line of CreditUSD (m); Debt Instrument, Unamortized Discount, CurrentUSD (m).
- 2021-09-30: Long-term Debt, Current MaturitiesUSD $3.74M; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term Line of CreditUSD (m); Debt Instrument, Unamortized Discount, CurrentUSD $6.00K.
- 2021-06-30: Long-term Debt, Current MaturitiesUSD $5.61M; Long-term Debt, Excluding Current MaturitiesUSD $0.00; Long-term Line of CreditUSD (m); Debt Instrument, Unamortized Discount, CurrentUSD $14.00K.
- 2021-03-31: Long-term Debt, Current MaturitiesUSD $7.47M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Line of CreditUSD (m); Debt Instrument, Unamortized Discount, CurrentUSD $26.00K.
COMPASS THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Line of Credit USD | Debt Instrument, Unamortized Discount, Current USD | Debt Instrument, Unamortized Discount, Noncurrent USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 | $0.00 | (m) | (m) | (m) | (m) |
| 2021-09-30 | $3.74M | $0.00 | (m) | $6.00K | $0.00 | (m) |
| 2021-06-30 | $5.61M | $0.00 | (m) | $14.00K | $0.00 | (m) |
| 2021-03-31 | $7.47M | (m) | (m) | $26.00K | (m) | (m) |
| 2020-12-31 | $7.47M | $1.87M | $100.00K | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $33.00K | $8.00K | (m) |
| 2020-09-30 | $7.46M | $3.73M | (m) | $39.00K | $20.00K | (m) |
| 2020-06-30 | $7.45M | $5.59M | (m) | $46.00K | $35.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $103.11K |
| 2019-12-31 | $5.58M | $9.29M | (m) | $49.00K | $82.00K | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $93.11K |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $85.61K |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $72.12K |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $72.12K |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $62.12K |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | $49.62K |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | $49.62K |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | $34.52K |
| 2016-07-01 | (m) | (m) | $100.00K | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |